DROPPING TODAY Biotechnology $10.74B Cap Quant: HOLD

Why Is Moderna, Inc. (MRNA) Stock Down Today?

Updated Nov 17, 2026 7:30 PM ET · Prev Close $215.27

Pro Workspace
Last Session Price
$205.74 -4.43%
-$9.53 vs $215.27 prior close
Intraday Range
$204.52 – $222.43
Open $219.85
Relative Volume
0.32x Avg
4,502,229 sh
52-Week Range
$114.46 – $280.80
Benchmark Alpha
-3.52% vs SPY
-3.64% vs QQQ
20-Session Trend -16.3%

Primary Move Catalyst & Conviction

70% Signal Conviction
OPTIONS 75% Driver Weight

Unusual Put buying detected

Options traders are heavily buying puts on MRNA, with 72% of volume in puts. This suggests bearish institutional positioning.

SECTOR 65% Weight
Biotechnology & Biological Products sector moving together

This appears to be a sector-wide move. The Biotechnology & Biological Products sector is down 2.2% on average.

Volume Confirmation
LOW VOLUME (0.32x) Unconfirmed
Sub-average participation — monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 70%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

MRNA lagging the S&P 500 by -3.52%
MRNA Session
-4.43%
$205.74
S&P 500 (SPY)
-0.91%
$733.21
Nasdaq 100 (QQQ)
-0.79%
$656.55
Healthcare (XLV)
-0.94%
$186.12
Alpha vs SPY: -3.52% Alpha vs QQQ: -3.64% Alpha vs XLV: -3.49%
Peer Group: Biotechnology & Biological Products (-2.3% avg) Lagging peers by -2.2%

Options Flow & Execution Desk

Neutral Flow · P/C 0.84
Call Volume
20,096
Contracts
Put Volume
16,810
Contracts
Put / Call Ratio
0.84
36,906 total vol
Implied Volatility
115.1%
Chain avg IV
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $215.27 · IV 83.7%

After MRNA's -4.4% Drop: Simulated 5-Day Bounce, Put-Wall & Downside Payoffs

Compare deploying $21,527 for 100 MRNA shares against capped-risk 5-day option structures priced at 83.7% ATM implied volatility.

5-DAY OVERSOLD BOUNCE Liq A

Dec 18 $220 / $260 Bull Call Spread

Buy 1x $220C · Sell 1x $260C · 32d

Net Entry $1,105 Debit
T+5d @ +5% Move +$267 (+24%)
Max Risk / Buffer $1,105 Capped
5d Edge & Liquidity 0.7x R:R · Liq A
Simulate 5-Day Payoff →
POST-DROP PUT-WALL INCOME Liq A

Dec 18 $190 / $180 Bull Put Spread

Sell 1x $190P · Buy 1x $180P · 32d

Net Entry $255 Credit
Max Credit / Yield +$255 (+34.2% RoM)
Max Risk / Buffer -12.9% Cushion ($745 Mgn)
5d Edge & Liquidity 74% PoP · Liq A
Simulate 5-Day Payoff →
5-DAY BREAKDOWN SPREAD Liq A

Dec 18 $230 / $190 Bear Put Spread

Buy 1x $230P · Sell 1x $190P · 32d

Net Entry $1,817 Debit
T+5d @ -5% Drop +$353 (+19%)
Max Risk / Buffer $1,817 Capped
5d Edge & Liquidity 0.8x R:R · Liq A
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Unlock 3 Unusual MRNA Options Sweep Strikes

See exact institutional strike concentrations, volume-to-OI ratios, and multi-leg payoff blueprints with Tradestie Pro.

Recent MRNA Catalyst Headlines

Verified Wire

1–3 Day Expected Range & Key Level

45% Follow-Through
Lower Bound
$199.56
Short-term support band
Upper Bound
$209.85
Short-term resistance band
Key Inflection Level
$195.45 (support)

Watch for breakdown below $205.74

Technical Regime (MRNA)

MIXED MA TREND
RSI (14)
44.5
Bearish
20-Day SMA
$228.10
Below 20d
50-Day SMA
$204.38
Above 50d
MACD Signal
Bearish
MACD 6.25
ADX (14)
32.8
Strong trend
10d Momentum
-22.30
Strong downward 10-day pressure

1-Year Historical Move Analogs

17 Events

Sessions in the past year where MRNA moved >3.0% down:

Continuation Rate
52.9%
9/17 sessions
Avg Next-Day Move
+0.85%
T+1 session return
Last analog: Nov 16, 2026 (-3.6%) → Next session: -4.4%

Retail & Crowd Sentiment

Bullish
24h Messages
38
7d avg 38.3
Bullish / Bearish
60.5% / 39.5%
High buzz
Crowd Discussion Digest

StockTwits messages express bullish sentiment towards Moderna ($MRNA) due to its potential cancer vaccine, with some traders regretting missed opportunities. The latest Yahoo Finance article discusses Moderna's stock performance and growth expectations, suggesting that the stock may be overvalued.

Reddit communities: 1 comment (Bullish)

About Moderna, Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clin...

Sector
Healthcare
Market Cap
$10.74B
Employees
5,800

Get Instant MRNA Catalyst Alerts

Receive an email alert when MRNA triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

MRNA Session & Catalyst FAQ

Why is MRNA stock down today?

Options traders are heavily buying puts on MRNA, with 72% of volume in puts. This suggests bearish institutional positioning.

Is MRNA stock a buy or sell right now?

Today's session carries a 70% catalyst conviction score on 0.32x relative volume (low participation). Our multi-factor model currently rates MRNA as HOLD. Review full valuation, quality, and timing signals on the MRNA Buy or Sell Decision Brief →

What is MRNA's intrinsic value and expected trading range?

At $205.74, MRNA's modeled 1-to-3 session range is $199.56 – $209.85, with a key inflection level at $195.45 (support). Compare current price against multi-year cash flow projections in the MRNA Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for MRNA?

RSI at 44.5 reflects soft below-midline momentum. MRNA trades at $205.74 relative to its 20-day SMA ($228.10) and 50-day SMA ($204.38), reflecting a mixed moving-average structure.

Tradestie Flagship Research & Market Hubs